Oncolytic Virus‐Driven Biotherapies from Bench to Bedside (Small 23/2023)

Oncolytic Virotherapies In article number 2206948, Ying Wu, Ning Li, Funan Liu, and co‐workers provide a more advanced approach to cancer immunotherapy, i.e. the oncolytic virotherapy. Oncolytic viruses selectively replicate in tumor cells and exert antitumor effects through direct oncolysis and ind...

Full description

Saved in:
Bibliographic Details
Published in:Small (Weinheim an der Bergstrasse, Germany) Germany), 2023-06, Vol.19 (23), p.n/a
Main Authors: Duan, Shijie, Wang, Shuhang, Qiao, Lei, Yu, Xinbo, Wang, Nan, Chen, Liting, Zhang, Xinyuan, Zhao, Xu, Liu, Hongyu, Wang, Tianye, Wu, Ying, Li, Ning, Liu, Funan
Format: Article
Language:English
Subjects:
antitumor mechanisms
clinical trials
intravenous administration
oncolytic viruses
traditional cancer therapies
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Oncolytic Virotherapies In article number 2206948, Ying Wu, Ning Li, Funan Liu, and co‐workers provide a more advanced approach to cancer immunotherapy, i.e. the oncolytic virotherapy. Oncolytic viruses selectively replicate in tumor cells and exert antitumor effects through direct oncolysis and inducting immune responses, where tumor antigens from the lysing cells enhance antitumor immunity.
ISSN:1613-6810
1613-6829
DOI:10.1002/smll.202370163